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as a carrier of tetracycline resistance and phage receptor genes. The mechanistic 85 basis for the poor RP4 conjugation in these E. cloacae strains is unclear. Given that 86 the phage is still infective, it could be that ANC C2 rifampicin-resistant mutant was 87 an impotent recipient for the plasmid rather than that 11.1B(RP4) lacked the ability 88 to express pili. Although rifampicin resistance mutations are most often polymerase 89 related, known mechanisms in Enterobacteriaceae include elongated or abundant 90 outer membrane LPS-chains [16] that could theoretically interfere with conjugation 91
(but see: [17] ). 92
The in vitro experiment used 200 μl cultures on a 96-well plate with LB and 93 0.1% starting frequency of plasmid. 24 replicate populations were subjected to full 94 factorial antibiotic (AB) and phage (P) treatment: AB-P-, AB-P+, AB+ P-, and AB+ 95 P+, respectively. The antibiotic treatments were set to 12 μg/mL tetracycline and 96 phage starting density to 5 × 10 7 phage particles. The growth in optical density 97 (600nm) was recorded at 24 h with a spectrophotometer in 30°C. Plasmid frequency 98 and transconjugants were sampled from a subset (N=44) of populations at 24 h by 99 selective plating. 100
The T.ni were maintained as follows: The adults, fed with 100mM sucrose 101 solution, were let to mate and lay eggs on paper strips in flight chambers. The eggs 102 were placed in autoclaved, single-filter vented, 305 x 203 x 100mm Genesis™ 103 containers for surgical instruments to maintain sterile conditions while allowing gas 104 exchange. Hatched larvae were let to feed on Hoffman diet (288 g wheatgerm, 132 g 105 caesin, 117 g sucrose, 70 g agar, 57 g dried brewers yeast, 37.5 g Wesson's salts, 6 g vitamin mixture in 2750 ml water) [18] . The liquid medium was poured into a sterile 108 steel mould and solidified to diet cubes with approximately 25mm edges. The cubes 109 were placed on Petri dish covers inside the containers. All rearing and in vivo 110 bacterial work was carried out in 25 °C. For population maintenance, 50-60 pupae 111 were removed from their cocoons per flight chamber and let to emerge and mate to 112 start a new generation of hosts. 113
For inoculating the larval gut with E. cloacae, clones ANC C2 and 11.1B 114 bearing RP4 were grown over night in LB (30 °C, 180 rpm shaking), the latter diluted 115 1:10 with 0.85 % NaCl, and then mixed together in a 50:1 ratio. The frequency of the 116 plasmid bearing cells was counted by dilution plating as 0.072% and bacterial density 117 approximately 1.2 × 10 8 CFU. Diet cubes were dipped in this solution, dried for 5 min, 118 and 3 rd instar larvae were allowed to feed on this bacterial diet for 30 h. The larvae 119
were then subjected to the AB-P-, AB-P+, AB+ P-, and AB+ P+ treatments. 120
Tetracycline (200 μg/mL final concentration) was added directly to the autoclaved 121 diet mix and 30 μl of 10 10 pfu/mL filtered phage lysate was pipetted onto each face 122 of the phage treatment diet cubes. The experiment was carried out in two 123 independent batches (final N=156 larvae). After 96 h, the larvae were surface 124 sterilised with 70% alcohol and homogenised in 500 μl 0.85% NaCl with Qiagen 125
Tissuelyser II™. The homogenate was serially diluted and plated on 12 μg/mL 126 tetracycline, 12 μg/mL tetracycline + 100 μg/mL rifampicin, and LB plates to calculate 127 the frequencies of plasmid carriers, transconjugants, and total density of bacteria. 24 128 bacterial clones from the phage treatment serial dilutions on tetracycline were Phage survival in the gut was confirmed by overlaying homogenised larval faecal been reported to be of low cost and rapidly evolve towards no cost through 154 chromosomal compensatory mutations [19] . 155
In vivo patterns of plasmid dynamics were mainly similar to that observed in 156 vitro, but the effects smaller. The non-targeted strain could fully compensate for the 157 reduction in density of the competing strain (AB: F 1, 156 =0.1, p=0.77), and phage had 158 no main effect on total bacterial load (P: F 1, 156 =3.0, p=0.085). Phage however 159 lowered bacterial density in the presence of antibiotics (interaction: F 1, 156 =6.7, 160 p=0.011), demonstrating that the treatment synergism was maintained in vivo (post 161 hoc AB+ P-and AB+ P+, p=0.020, Fig. 2 . a). Plasmid increased in frequency in all 162 treatments but tetracycline selection drove the majority of the population to be 163 plasmid carriers with no effects of phage addition (effects on plasmid frequency, AB: 164 F 1, 156 =845.0, p<0.001; P: F 1, 156 =0.6, p=0.43; AB*P: F 1, 156 =0.4, p=0.55 ( Fig. 2. b ). Thus, 165 phage therapy could not restrict the spread of antibiotic resistance in the T. ni gut. 166
DISCUSSION 167
Here, we investigated the effect of plasmid-targeting phage on the spread of 168 antibiotic resistance plasmid in vitro and in an insect gut model. Generally, the 169 complex environment in the gut made treatment effects less pronounced compared 170 to the liquid culture: apparently the spatial structures protected the plasmid from 171 extinction in the absence of antibiotics, and allowed more non-resistant bacteria to 172 coexist in the presence of tetracycline. This happened even though the antibiotic 173 concentration in the diet was over 16 times higher than in the liquid culture and the 174 experiment length 4 times longer, allowing more time for potential fixation and/or presence of tetracycline was also more moderate in vivo but it is also notable that no 177 detectable phage resistance emerged in the sampled populations. Surprisingly, 178
antibiotics did not reduce the overall bacterial density in the gut, but rather replaced 179 non-resistant cells with resistant ones while population size remained the same. In 180 other words, antibiotics increased the relative fitness of the resistant strain without 181
reducing the absolute fitness [20] . This was in contrast with liquid culture where the 182 plasmid went even closer to fixation in the presence of antibiotics but resulted in 183 lower total bacterial density, which suggests a greater growth cost associated with 184 antibiotic resistance in vitro. We cannot attribute the inversion of fitness effects 185 between in vivo and in vitro conditions (increase in plasmid frequency in vivo, and 186 extinction in vitro in absence of antibiotics) directly to the plasmid, because it could 187 also be due to the differences in the mutant strains. The result still highlights the 188 limitations of making inferences from test tube dynamics. 189
In the absence of antibiotics neither in vitro nor in vivo regimes showed a 190 phage effect on the bacterial population size, which was not surprising because of 
